Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Phase II Multicenter Trial of Oltipraz for the Evaluation of Efficacy and Safety in the Patients With Liver Fibrosis and Cirrhosis Induced by Chronic Hepatitis Type B or C

NCT00956098 is registered in ClinicalTrials.gov with HK inno.N Corporation as lead sponsor.

NCT NCT00956098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00956098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Phase II Multicenter Trial of Oltipraz for the Evaluation of Efficacy and Safety in the Patients With Liver Fibrosis and Cirrhosis Induced by Chronic Hepatitis Type B or C
Lead sponsor
HK inno.N Corporation
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2006
Completion date
February 28, 2007
Enrollment
81
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis, liver fibrosis